These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12839144)

  • 1. Treatment of osteoporosis: combination therapies.
    Simon JA; Mack CJ
    Int J Fertil Womens Med; 2003; 48(3):127-31; discussion 137-8. PubMed ID: 12839144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapies to improve bone mineral density and reduce the risk of fracture: clinical trial results.
    Watts NB
    J Reprod Med; 2002 Jan; 47(1 Suppl):82-92. PubMed ID: 11829081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FPIN's clinical inquiries. Combination therapy for postmenopausal osteoporosis.
    Howard E; Tagliarino-Jones H
    Am Fam Physician; 2010 Feb; 81(4):439. PubMed ID: 20148496
    [No Abstract]   [Full Text] [Related]  

  • 5. Drugs for prevention and treatment of postmenopausal osteoporosis.
    Treat Guidel Med Lett; 2002 Nov; 1(3):13-8. PubMed ID: 15529101
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of SERMs on bone health. Combination therapy with raloxifene].
    Gorai I; Hori H
    Clin Calcium; 2010 Mar; 20(3):408-12. PubMed ID: 20190371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiresorptive treatment of postmenopausal osteoporosis: review of randomized clinical studies and rationale for the Evista alendronate comparison (EVA) trial.
    Lufkin EG; Sarkar S; Kulkarni PM; Ciaccia AV; Siddhanti S; Stock J; Plouffe L
    Curr Med Res Opin; 2004 Mar; 20(3):351-7. PubMed ID: 15025844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combination therapy for osteoporosis].
    Kishimoto H
    Nihon Rinsho; 2009 May; 67(5):975-9. PubMed ID: 19432119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New development in bisphosphonate treatment. Clinical significance of combinatorial therapies with bisphosphonates and parathyroid hormone for osteoporosis].
    Takeuchi Y
    Clin Calcium; 2009 Jan; 19(1):85-90. PubMed ID: 19122268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic prevention of osteoporotic fractures.
    Zizic TM
    Am Fam Physician; 2004 Oct; 70(7):1293-300. PubMed ID: 15508540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
    Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
    Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of fracture and treatment to prevent osteoporosis-related fracture in postmenopausal women. A review.
    Martens MG
    J Reprod Med; 2003 Jun; 48(6):425-34. PubMed ID: 12856513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapies for osteoporosis.
    Jamal SA
    J Am Pharm Assoc (2003); 2004; 44(2):119; author reply 119. PubMed ID: 15098843
    [No Abstract]   [Full Text] [Related]  

  • 15. [Anabolic treatment for osteoporosis: PTH treatment].
    Kaji H; Sugimoto T
    Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Postmenopausal osteoporosis].
    László A
    Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
    Ohta H
    Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose estrogen therapy for prevention of osteoporosis: working our way back to monotherapy.
    Richman S; Edusa V; Fadiel A; Naftolin F
    Menopause; 2006; 13(1):148-55. PubMed ID: 16607111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteoporosis therapy compared. More solid bones with bisphosphonates].
    MMW Fortschr Med; 2003 Aug; 145(31-32):55. PubMed ID: 14524081
    [No Abstract]   [Full Text] [Related]  

  • 20. [Evidence-based assessment of therapeutic agents of osteoporosis. Bisphosphonates, SERM and basic therapy in front].
    MMW Fortschr Med; 2003 Jul; 145(27-28):63. PubMed ID: 14587198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.